Your browser doesn't support javascript.
loading
Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples.
Postnikova, Elena N; Pettitt, James; Van Ryn, Collin J; Holbrook, Michael R; Bollinger, Laura; Yú, Shuǐqìng; Caì, Yíngyún; Liang, Janie; Sneller, Michael C; Jahrling, Peter B; Hensley, Lisa E; Kuhn, Jens H; Fallah, Mosoka P; Bennett, Richard S; Reilly, Cavan.
Afiliación
  • Postnikova EN; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Pettitt J; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Van Ryn CJ; Coordinating Centers for Biometric Research, Division of Biostatistics, University of Minnesota, Minneapolis, MN, United States of America.
  • Holbrook MR; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Bollinger L; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Yú S; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Caì Y; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Liang J; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Dr, Bethesda, MD, United States of America.
  • Jahrling PB; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Hensley LE; Emerging Viral Pathogens Section, Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Fort Detrick, Frederick, Maryland, United States of America.
  • Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Fallah MP; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
  • Bennett RS; National Public Health Institute of Liberia, Monrovia, Liberia.
  • Reilly C; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Research Plaza, Frederick, MD, United States of America.
PLoS One ; 14(8): e0221407, 2019.
Article en En | MEDLINE | ID: mdl-31454374
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus / Anticuerpos Neutralizantes / Anticuerpos Antivirales Tipo de estudio: Qualitative_research Límite: Animals / Humans País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus / Anticuerpos Neutralizantes / Anticuerpos Antivirales Tipo de estudio: Qualitative_research Límite: Animals / Humans País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos